None listed
Conditions
Interventions
Drug : Participants with primary adhesive capsulitis in the freezing stage were randomly assigned to receive blind intra-articular injections with 40 mg triamcinolone acetonide (high-dose group), or 2
Sponsors
Ajou University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Age, 20 to 70 years old (2) stage 2 (freezing stage) of adhesive capsulitis at least 1 month of pain duration: pain and stiffness in predominantly one shoulder for =1 months (3) average pain intensity during a day defined as a score of 5 points or more on a 10-cm visual analog scale (VAS) rated from 0 (no pain) to 10 (worst imaginable pain)
Exclusion criteria
Exclusion criteria: (1) Secondary adhesive capsulitis (suspicious of secondary to other causes including inflammatory, metabolic, or infectious arthritis; cerebrovascular accident; tumor; or fracture) (2) Definite rotator cuff lesion; complete or full-thickness tear of the rotator cuff (3) Previous corticosteroid injection at the affected shoulder within 1 month (4) High-risk bleeding tendency; taking medication such as an anticoagulant with the exception of those who agreed to stop for a minimum of 5 days before the injection. (5) Uncontrolled serum glucose level in diabetes patient (>180mg/dl) (6) Previous history of shoulder surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shoulder pain and disability index | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall shoulder pain using a visual analog scale;Passive range of motion of shoulder | — |
Countries
Korea, Republic of
Contacts
Public ContactSeung-Hyun Yoon
Ajou University Hospital
Outcome results
None listed